The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

74 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.EBI
Washington University
Design and synthesis of benzodiazepine analogs as isoform-selective human lysine deacetylase inhibitors.EBI
Washington University
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.EBI
Washington University
Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate.EBI
Washington University
Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter.EBI
Washington University
Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands fora-Synuclein Fibrils.EBI
Washington University
Synthesis and in vitro characterization of cinnoline and benzimidazole analogues as phosphodiesterase 10A inhibitors.EBI
Washington University
Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.EBI
Washington University
Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.EBI
Washington University
Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer.EBI
Washington University
Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues ass2 receptor ligands.EBI
Washington University
Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate.EBI
Washington University
Thes2 receptor: a novel protein for the imaging and treatment of cancer.EBI
Washington University
Heteroaromatic and aniline derivatives of piperidines as potent ligands for vesicular acetylcholine transporter.EBI
Washington University
Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands.EBI
Washington University
Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii.EBI
Washington University
Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine.EBI
Washington University
Exploring new near-infrared fluorescent disulfide-based cyclic RGD peptide analogs for potential integrin-targeted optical imaging.EBI
Washington University
Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.EBI
Washington University
Derivation of a three-dimensional pharmacophore model of substance P antagonists bound to the neurokinin-1 receptor.EBI
Washington University
Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes.EBI
Washington University
Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.EBI
Washington University
Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and complementary-receptor-field alignment rules.EBI
Washington University
Synthesis, radiolabeling and initial in vivo evaluation of [(11)C]KSM-01 for imaging PPAR-a receptors.EBI
Washington University
Near-infrared fluorescent divalent RGD ligand for integrinavß3-targeted optical imaging.EBI
Washington University
Synthesis and in vitro evaluation ofa-synuclein ligands.EBI
Washington University
Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins.EBI
Washington University
Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquine.EBI
Washington University
Synthesis and evaluation of in vitro bioactivity for vesicular acetylcholine transporter inhibitors containing two carbonyl groups.EBI
Washington University
Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626.EBI
Washington University
Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.EBI
Washington University
Conformationally restricted TRH analogs: a probe for the pyroglutamate region.EBI
Washington University
Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: conformational and biological implications.EBI
Washington University
Effects of steroid D-ring modification on suicide inactivation and competitive inhibition of aromatase by analogues of androsta-1,4-diene-3,17-dione.EBI
Washington University
Synthesis and in vitro biological evaluation of carbonyl group-containing analogues fors1 receptors.EBI
Washington University
Synthesis and in vitro evaluation of new analogues as inhibitors for phosphodiesterase 10A.EBI
Washington University
Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound.EBI
Washington University
Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: introduction of a hydrophilic group increases potency in a whole cell assay.EBI
Washington University
Synthesis and pharmacological evaluation of fluorine-containing D3 dopamine receptor ligands.EBI
Washington University
Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir.EBI
Washington University
Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.EBI
Washington University
Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase.EBI
Washington University
New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.EBI
Washington University
Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening.EBI
Washington University
Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.EBI
Washington University
Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography.EBI
Washington University
Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis.EBI
Washington University
Synthesis and evaluation of highly selective quinazoline-2,4-dione ligands for sphingosine-1-phosphate receptor 2.EBI
Washington University
Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.EBI
Washington University
Conformations of trypsin-bound amidine inhibitors of blood coagulant factor Xa by double REDOR NMR and MD simulations.EBI
Washington University
Design, synthesis, and in vitro bioactivity evaluation of fluorine-containing analogues for sphingosine-1-phosphate 2 receptor.EBI
Washington University
Thyrotropin releasing hormone analogs: a building block approach to the construction of tetracyclic peptidomimetics.EBI
Washington University
Synthesis and evaluation of two positron-labeled nitric oxide synthase inhibitors, S-[11C]methylisothiourea and S-(2-[18F]fluoroethyl)isothiourea, as potential positron emission tomography tracers.EBI
Washington University
Multiple binding modes for the receptor-bound conformations of cyclic AII agonists.EBI
Washington University
Structural determinants of haloenol lactone-mediated suicide inhibition of canine myocardial calcium-independent phospholipase A2.EBI
Washington University
Ac-[3- and 4-alkylthioproline31]-CCK4 analogs: synthesis and implications for the CCK-B receptor-bound conformation.EBI
Washington University
N-fluoroalkylated and N-alkylated analogues of the dopaminergic D-2 receptor antagonist raclopride.EBI
Washington University
Trifluoromethylacetylenic alcohols as affinity labels: inactivation of estradiol dehydrogenase by a trifluoromethylacetylenic secostradiol.EBI
Washington University
ESTROGEN RECEPTOR ANTAGONISTBDB
Shenzhen Forward Pharmaceuticals Co.
NOVEL DIOXANE DERIVATIVESBDB
Boehringer Ingelheim International
POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1BDB
Dana-Farber Cancer Institute
Heteroaryl inhibitors of PDE4BDB
Tetra Discovery Partners
Substituted benzimidazoles, their preparation and their use as pharmaceuticalsBDB
Neomed Institute
Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activityBDB
Merck Patent
Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]BDB
Phenex Pharmaceuticals
Organic compoundsBDB
Intra-Cellular Therapies
Benzothiazoles having histamine H3 receptor activityBDB
High Point Pharmaceuticals
Disubstituted heteroaryl-fused pyridinesBDB
Novartis
Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors.BDB
Medical University of Lodz
IRE-1α inhibitorsBDB
Mannkind
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.BDB
Dupont Pharmaceuticals